Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.
暂无分享,去创建一个
Milo A Puhan | C. Meinert | M. Puhan | M. V. Van Natta | F. Palella | Mark L Van Natta | Curtis Meinert | Frank J Palella | Adrienne Addessi | A. Addessi
[1] Kholoud Porter,et al. Survival following HIV infection of a cohort followed up from seroconversion in the UK , 2008, AIDS.
[2] H. Brenner,et al. On crude and age-adjusted relative survival rates. , 2003, Journal of clinical epidemiology.
[3] John T Brooks,et al. Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study , 2006, Journal of acquired immune deficiency syndromes.
[4] Anne M Johnson,et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. , 2008, JAMA.
[5] O. Kirk,et al. Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study , 2003, AIDS.
[6] Gitte Pedersen,et al. Survival of Persons with and without HIV Infection in Denmark, 19952005 , 2007, Annals of Internal Medicine.
[7] G. Satten,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.
[8] Amalio Telenti,et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population , 2003, The Lancet.
[9] J. Kempen,et al. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. , 2007, Ophthalmology.
[10] J. Kempen,et al. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. , 2007, Ophthalmology.
[11] Isma'il ibn Ali al-Sadiq. AIDS , 1986, The Lancet.
[12] R. B. House,et al. At the University of North Carolina , 1945 .
[13] P. Kissinger,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.
[14] Jonathan AC Sterne,et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies , 2002, The Lancet.
[15] C Kupfer,et al. The National Eye Institute. , 1972, American journal of ophthalmology.
[16] Paul W Dickman,et al. Regression models for relative survival , 2004, Statistics in medicine.
[17] Paul C. Lambert,et al. Modeling of the Cure Fraction in Survival Studies , 2007 .
[18] R. Geskus,et al. Declining AIDS Mortality in Amsterdam: Contributions of Declining HIV Incidence and Effective Therapy , 2004, Epidemiology.